Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Cobbe

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Evidence-Based Cardiovascular Medicine|December 29, 2005
Reductase inhibitor monotherapy for cholesterol reduction lowered the incidence of strokeS M Cobbe
Heart (British Cardiac Society)|February 1, 1996
Class III Antiarrhythmics: put to the SWORD?S M Cobbe
Pacing and Clinical Electrophysiology : PACE|May 1, 1994
Incidence and risks associated with atrial fibrillationS M Cobbe
European Heart Journal|April 1, 1994
Drug therapy of supraventricular tachyarrhythmias--based on efficacy or futility?S M Cobbe
Cardiovascular Research|December 1, 1988
Modification of class III anti-arrhythmic activity in abnormal myocardiumS M Cobbe
British Medical Journal (Clinical Research Ed.)|January 12, 1985
Sudden cardiac death and acute coronary thrombosisS M Cobbe
British Journal of Hospital Medicine|March 1, 1980
Pericardial effusionsS M Cobbe
BMJ (Clinical Research Ed.)|January 22, 1994
Thrombolysis in myocardial infarctionS M Cobbe
British Medical Journal (Clinical Research Ed.)|June 4, 1983
Congenital complete heart blockS M Cobbe
European Heart Journal|March 1, 1987
Clinical usefulness of the Vaughan Williams classification systemS M Cobbe
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Evidence-Based Cardiovascular Medicine|December 29, 2005
Reductase inhibitor monotherapy for cholesterol reduction lowered the incidence of strokeS M Cobbe
Heart (British Cardiac Society)|February 1, 1996
Class III Antiarrhythmics: put to the SWORD?S M Cobbe
Pacing and Clinical Electrophysiology : PACE|May 1, 1994
Incidence and risks associated with atrial fibrillationS M Cobbe
European Heart Journal|April 1, 1994
Drug therapy of supraventricular tachyarrhythmias--based on efficacy or futility?S M Cobbe
Cardiovascular Research|December 1, 1988
Modification of class III anti-arrhythmic activity in abnormal myocardiumS M Cobbe
British Medical Journal (Clinical Research Ed.)|January 12, 1985
Sudden cardiac death and acute coronary thrombosisS M Cobbe
British Journal of Hospital Medicine|March 1, 1980
Pericardial effusionsS M Cobbe
BMJ (Clinical Research Ed.)|January 22, 1994
Thrombolysis in myocardial infarctionS M Cobbe
British Medical Journal (Clinical Research Ed.)|June 4, 1983
Congenital complete heart blockS M Cobbe
European Heart Journal|March 1, 1987
Clinical usefulness of the Vaughan Williams classification systemS M Cobbe
Pageof 19